Cargando…
Basal cell carcinomas acquire secondary mutations to overcome dormancy and progress from microscopic to macroscopic disease
Basal cell carcinomas (BCCs) frequently possess immense mutational burdens; however, the functional significance of most of these mutations remains unclear. Here, we report that loss of Ptch1, the most common mutation that activates upstream Hedgehog (Hh) signaling, initiates the formation of nascen...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127636/ https://www.ncbi.nlm.nih.gov/pubmed/35508126 http://dx.doi.org/10.1016/j.celrep.2022.110779 |
_version_ | 1784712395902418944 |
---|---|
author | Trieu, Kenneth G. Tsai, Shih-Ying Eberl, Markus Ju, Virginia Ford, Noah C. Doane, Owen J. Peterson, Jamie K. Veniaminova, Natalia A. Grachtchouk, Marina Harms, Paul W. Swartling, Fredrik J. Dlugosz, Andrzej A. Wong, Sunny Y. |
author_facet | Trieu, Kenneth G. Tsai, Shih-Ying Eberl, Markus Ju, Virginia Ford, Noah C. Doane, Owen J. Peterson, Jamie K. Veniaminova, Natalia A. Grachtchouk, Marina Harms, Paul W. Swartling, Fredrik J. Dlugosz, Andrzej A. Wong, Sunny Y. |
author_sort | Trieu, Kenneth G. |
collection | PubMed |
description | Basal cell carcinomas (BCCs) frequently possess immense mutational burdens; however, the functional significance of most of these mutations remains unclear. Here, we report that loss of Ptch1, the most common mutation that activates upstream Hedgehog (Hh) signaling, initiates the formation of nascent BCC-like tumors that eventually enter into a dormant state. However, rare tumors that overcome dormancy acquire the ability to hyperactivate downstream Hh signaling through a variety of mechanisms, including amplification of Gli1/2 and upregulation of Mycn. Furthermore, we demonstrate that MYCN overexpression promotes the progression of tumors induced by loss of Ptch1. These findings suggest that canonical mutations that activate upstream Hh signaling are necessary, but not sufficient, for BCC to fully progress. Rather, tumors likely acquire secondary mutations that further hyperactivate downstream Hh signaling in order to escape dormancy and enter a trajectory of uncontrolled expansion. |
format | Online Article Text |
id | pubmed-9127636 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
record_format | MEDLINE/PubMed |
spelling | pubmed-91276362022-05-24 Basal cell carcinomas acquire secondary mutations to overcome dormancy and progress from microscopic to macroscopic disease Trieu, Kenneth G. Tsai, Shih-Ying Eberl, Markus Ju, Virginia Ford, Noah C. Doane, Owen J. Peterson, Jamie K. Veniaminova, Natalia A. Grachtchouk, Marina Harms, Paul W. Swartling, Fredrik J. Dlugosz, Andrzej A. Wong, Sunny Y. Cell Rep Article Basal cell carcinomas (BCCs) frequently possess immense mutational burdens; however, the functional significance of most of these mutations remains unclear. Here, we report that loss of Ptch1, the most common mutation that activates upstream Hedgehog (Hh) signaling, initiates the formation of nascent BCC-like tumors that eventually enter into a dormant state. However, rare tumors that overcome dormancy acquire the ability to hyperactivate downstream Hh signaling through a variety of mechanisms, including amplification of Gli1/2 and upregulation of Mycn. Furthermore, we demonstrate that MYCN overexpression promotes the progression of tumors induced by loss of Ptch1. These findings suggest that canonical mutations that activate upstream Hh signaling are necessary, but not sufficient, for BCC to fully progress. Rather, tumors likely acquire secondary mutations that further hyperactivate downstream Hh signaling in order to escape dormancy and enter a trajectory of uncontrolled expansion. 2022-05-03 /pmc/articles/PMC9127636/ /pubmed/35508126 http://dx.doi.org/10.1016/j.celrep.2022.110779 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ). |
spellingShingle | Article Trieu, Kenneth G. Tsai, Shih-Ying Eberl, Markus Ju, Virginia Ford, Noah C. Doane, Owen J. Peterson, Jamie K. Veniaminova, Natalia A. Grachtchouk, Marina Harms, Paul W. Swartling, Fredrik J. Dlugosz, Andrzej A. Wong, Sunny Y. Basal cell carcinomas acquire secondary mutations to overcome dormancy and progress from microscopic to macroscopic disease |
title | Basal cell carcinomas acquire secondary mutations to overcome dormancy and progress from microscopic to macroscopic disease |
title_full | Basal cell carcinomas acquire secondary mutations to overcome dormancy and progress from microscopic to macroscopic disease |
title_fullStr | Basal cell carcinomas acquire secondary mutations to overcome dormancy and progress from microscopic to macroscopic disease |
title_full_unstemmed | Basal cell carcinomas acquire secondary mutations to overcome dormancy and progress from microscopic to macroscopic disease |
title_short | Basal cell carcinomas acquire secondary mutations to overcome dormancy and progress from microscopic to macroscopic disease |
title_sort | basal cell carcinomas acquire secondary mutations to overcome dormancy and progress from microscopic to macroscopic disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127636/ https://www.ncbi.nlm.nih.gov/pubmed/35508126 http://dx.doi.org/10.1016/j.celrep.2022.110779 |
work_keys_str_mv | AT trieukennethg basalcellcarcinomasacquiresecondarymutationstoovercomedormancyandprogressfrommicroscopictomacroscopicdisease AT tsaishihying basalcellcarcinomasacquiresecondarymutationstoovercomedormancyandprogressfrommicroscopictomacroscopicdisease AT eberlmarkus basalcellcarcinomasacquiresecondarymutationstoovercomedormancyandprogressfrommicroscopictomacroscopicdisease AT juvirginia basalcellcarcinomasacquiresecondarymutationstoovercomedormancyandprogressfrommicroscopictomacroscopicdisease AT fordnoahc basalcellcarcinomasacquiresecondarymutationstoovercomedormancyandprogressfrommicroscopictomacroscopicdisease AT doaneowenj basalcellcarcinomasacquiresecondarymutationstoovercomedormancyandprogressfrommicroscopictomacroscopicdisease AT petersonjamiek basalcellcarcinomasacquiresecondarymutationstoovercomedormancyandprogressfrommicroscopictomacroscopicdisease AT veniaminovanataliaa basalcellcarcinomasacquiresecondarymutationstoovercomedormancyandprogressfrommicroscopictomacroscopicdisease AT grachtchoukmarina basalcellcarcinomasacquiresecondarymutationstoovercomedormancyandprogressfrommicroscopictomacroscopicdisease AT harmspaulw basalcellcarcinomasacquiresecondarymutationstoovercomedormancyandprogressfrommicroscopictomacroscopicdisease AT swartlingfredrikj basalcellcarcinomasacquiresecondarymutationstoovercomedormancyandprogressfrommicroscopictomacroscopicdisease AT dlugoszandrzeja basalcellcarcinomasacquiresecondarymutationstoovercomedormancyandprogressfrommicroscopictomacroscopicdisease AT wongsunnyy basalcellcarcinomasacquiresecondarymutationstoovercomedormancyandprogressfrommicroscopictomacroscopicdisease |